5/8/2018 11:50 AM
The shares of Array Biopharma Inc (NASDAQ:ARRY) have struggled since peaking two months ago. However, ARRY stock has pulled back to a historically supportive trendline, suggesting it could be time to...
2/7/2018 10:59 AM
Biotech stocks Array Biopharma Inc (NASDAQ:ARRY) and Myriad Genetics, Inc. (NASDAQ:MYGN) received some bullish analyst attention this morning, although only one stock is higher at last check. Below, w...
1/22/2018 10:18 AM
Array Biopharma Inc (NASDAQ:ARRY) is up 13.7% to trade at $14.93, and earlier touched a 16-year high of $15.66, after Leerink upgraded the cancer treatment specialist to "outperform" from "market per...